Where I see patients (1)
My reviews
Selected research
-
Reversible therapeutic resistance in EGFR mutant lung cancer caused by RB1 loss induced lineage plasticity.
bioRxiv : the preprint server for biology
-
Associations of frailty with survival, hospitalization, functional decline, and toxicity among older adults with advanced non-small cell lung cancer.
The oncologist
-
Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung Cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Clinical trials
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Partic...
PFS is defined as the time from randomization to the first occurrence of disease progression, as determined by blinded independent central review (BICR) according to RECIST v1.1, or death from any cause (whichever occurs first)
Recruiting
4.9